Uterine Sarcoma Trial Results
Surgery Alone May Be Best for Early Endometrial Cancer
(Posted: 01/14/2009) - Results from a large international clinical trial show no evidence of benefit in terms of overall or recurrence-free survival for pelvic lymphadenectomy in women with early endometrial cancer, according to the Jan. 10, 2009, issue of the Lancet.
![](https://webarchive.library.unt.edu/web/20121002003446im_/http://www.cancer.gov/images/spacer.gif)
Ifosfamide Plus Paclitaxel Extends Life for Patients With Uterine Carcinosarcoma
(Posted: 03/05/2007) - Women with a rare, aggressive form of uterine cancer who were treated with the drugs ifosfamide and paclitaxel lived a median of five months longer than women who were treated with ifosfamide alone, according to the Feb. 10, 2007, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20121002003446im_/http://www.cancer.gov/images/spacer.gif)
(Posted: 01/14/2009) - Results from a large international clinical trial show no evidence of benefit in terms of overall or recurrence-free survival for pelvic lymphadenectomy in women with early endometrial cancer, according to the Jan. 10, 2009, issue of the Lancet.
![](https://webarchive.library.unt.edu/web/20121002003446im_/http://www.cancer.gov/images/spacer.gif)
Ifosfamide Plus Paclitaxel Extends Life for Patients With Uterine Carcinosarcoma
(Posted: 03/05/2007) - Women with a rare, aggressive form of uterine cancer who were treated with the drugs ifosfamide and paclitaxel lived a median of five months longer than women who were treated with ifosfamide alone, according to the Feb. 10, 2007, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20121002003446im_/http://www.cancer.gov/images/spacer.gif)